Latest Research on Vertigo (2025-2026)

By Dr. Prateek Porwal, ENT & Vertigo Specialist | Prime ENT Center, Hardoi
Your Expert Guide to the Latest Research on Vertigo | Last Updated: March 2026 | VAI Budapest 2025 Award Recipient

The field of vertigo management is advancing at an extraordinary pace. From wearable balance technology and advanced posturography platforms to refined diagnostic protocols and targeted medications, what we can offer patients today is remarkably different from even three years ago. As someone who treats hundreds of vertigo patients annually and stays current with international vestibular research, I want to share the most significant clinical advances that are genuinely changing outcomes for patients.

Balance Belt Technology: Wearable Vestibular Biofeedback

One of the most exciting developments in vestibular rehabilitation is the emergence of balance belt technology. These wearable biofeedback devices represent a paradigm shift in how we approach balance retraining and fall prevention in vestibular patients.

The balance belt is a lightweight device worn around the trunk that contains an array of vibrotactile actuators (small vibrating motors) and inertial sensors. It continuously monitors the wearer’s postural sway and body orientation in real time. When the patient begins to lean or sway beyond a preset threshold, the belt delivers gentle vibration cues on the side toward which they are leaning, prompting an automatic corrective response.

How it works: The belt’s accelerometers and gyroscopes detect trunk tilt and angular velocity. An onboard processor calculates deviation from vertical and activates tactile motors to provide directional feedback. The patient perceives this vibration and intuitively shifts their weight back toward center. Over time, this sensory substitution helps the brain recalibrate its balance control circuits, even when vestibular input is damaged or unreliable.

Clinical evidence: Studies published in 2024-2025 demonstrate that balance belt-assisted rehabilitation significantly reduces postural sway, decreases fall risk, and improves confidence in patients with bilateral vestibular hypofunction and chronic unilateral vestibular loss. Patients using the belt during vestibular rehabilitation therapy (VRT) sessions showed faster improvement compared to conventional VRT alone. Research from multiple European vestibular centers confirms these findings.

Clinical applications: The balance belt is particularly valuable for elderly patients with vestibular dysfunction and high fall risk, bilateral vestibular loss patients who struggle with conventional rehabilitation, patients recovering from vestibular neuritis who need accelerated balance retraining, and individuals with persistent postural instability despite standard VRT.

This also applies to seniors and older adults who may face similar symptoms.

My perspective: Balance belt technology is not widely available in India yet, but it represents the future of vestibular rehabilitation. At Prime ENT Center, we are evaluating options to incorporate this technology for our patients with chronic balance disorders.

Computerized Dynamic Posturography (CDP): The Gold Standard in Balance Assessment

Computerized Dynamic Posturography (CDP), also known simply as posturography, has become the gold standard for objectively assessing balance function. Unlike subjective clinical tests, CDP provides quantified, reproducible data on how well a patient maintains balance under controlled conditions.

What is CDP: The system consists of a force platform (which measures center of pressure) and a movable visual surround. The patient stands on the platform while the system systematically manipulates the three sensory inputs used for balance: vision (eyes open/closed, moving surround), somatosensory (fixed/sway-referenced platform), and vestibular (the constant reference when other inputs are altered). This is the Sensory Organization Test (SOT), which isolates each sensory contribution to balance.

What CDP reveals: CDP identifies which specific sensory system is impaired: visual dependence, somatosensory reliance, vestibular deficit, or a combination. It detects subtle balance impairments that may not be apparent on routine clinical examination. It is particularly useful for differentiating peripheral vestibular disorders from central pathology, and for documenting functional overlay or malingering in medicolegal cases.

2025-2026 advances: Newer CDP platforms now incorporate additional protocols beyond the classic SOT. Motor Control Tests (MCT) assess automatic postural responses to sudden platform translations, while Adaptation Tests evaluate the patient’s ability to adapt to repeated perturbations. Some advanced systems integrate head movement tracking and electromyography (EMG) for even more detailed analysis. The latest software uses normative databases adjusted for age, height, and weight, making results more clinically meaningful.

Clinical utility: I consider CDP essential for complete vestibular evaluation, especially in patients with unexplained imbalance, recurrent falls, or when the diagnosis is unclear after standard VNG testing. It is also invaluable for tracking rehabilitation progress objectively, as improvements in SOT scores correlate with real-world balance improvement.

Functional Head Impulse Test (fHIT): Beyond the Standard vHIT

While the video Head Impulse Test (vHIT) has been a breakthrough in diagnosing vestibular hypofunction by measuring the vestibulo-ocular reflex (VOR) gain, the functional Head Impulse Test (fHIT) takes this assessment a important step further. The fHIT measures not just VOR gain but the actual functional consequence of VOR impairment during active head movements.

How fHIT works: The patient wears lightweight goggles with a built-in display. During rapid head impulses (similar to vHIT), an optotype (letter or symbol) is briefly flashed on the display. The patient must identify the optotype correctly. If the VOR is functioning well, the image remains stable on the retina during the head movement, and the patient reads it correctly. If the VOR is impaired, the image will be blurred by retinal slip, and the patient will misidentify the target.

What fHIT adds beyond vHIT: Standard vHIT tells us the VOR gain number, but fHIT tells us whether that VOR impairment actually affects the patient’s ability to see clearly during head movements. This is the real-world functional deficit that matters to patients. Some patients with mildly reduced VOR gain function perfectly well (compensated), while others with seemingly adequate gain still have functional deficits. The fHIT captures this critical distinction.

Clinical significance in 2025-2026: Recent research demonstrates that fHIT is a superior predictor of fall risk and real-world disability compared to vHIT gain alone. It provides an objective measure of vestibular compensation that helps guide rehabilitation decisions. If a patient’s VOR gain is reduced but fHIT performance is normal, they have compensated well and may not need aggressive VRT. Conversely, normal VOR gain with impaired fHIT performance suggests central processing issues or incomplete compensation requiring targeted rehabilitation.

Rehabilitation monitoring: The fHIT is excellent for tracking rehabilitation progress. As VRT helps the brain develop compensatory strategies, fHIT scores improve, providing objective evidence of functional recovery. This is more meaningful to patients and referring physicians than abstract VOR gain numbers.

Center of Gravity (COG) Analysis: Precision Balance Mapping

Center of Gravity (COG) analysis is a critical component of modern vestibular and balance assessment. It measures the position and movement of a patient’s projected center of gravity relative to their base of support, providing a precise map of balance control.

What COG analysis reveals: When you stand still, your body is never truly stationary. Your COG constantly oscillates within a small area as your balance systems make continuous micro-adjustments. In vestibular patients, these oscillations become larger, asymmetric, or shifted in specific directions depending on the underlying pathology. COG analysis quantifies these patterns with high precision.

Clinical parameters measured: The key COG metrics include sway area (the total area covered by COG displacement), sway velocity (how fast the COG moves), directional preponderance (whether the patient tends to lean in a particular direction), and the limits of stability (how far the patient can intentionally shift their COG without losing balance). Each parameter provides different clinical information.

Diagnostic applications: COG analysis is particularly useful in differentiating peripheral versus central vestibular lesions, as the sway patterns differ characteristically. In peripheral vestibular loss, the COG typically shifts toward the affected side. In central lesions, sway patterns are often multidirectional or atypical. COG data also helps identify patients with functional dizziness (PPPD), where characteristic high-frequency, low-amplitude sway patterns differ from those of organic vestibular disease.

Integration with rehabilitation: COG analysis data directly guides vestibular rehabilitation protocols. If a patient’s limits of stability are reduced in a specific direction, exercises targeting that direction can be prescribed. Real-time COG biofeedback during balance exercises helps patients understand and correct their postural tendencies, accelerating improvement.

Craniocorpography (CCG): Tracking Head and Body Movement Patterns

Craniocorpography (CCG) is an advanced diagnostic technique that records and analyzes the movement patterns of the head and body during specific balance tasks. Originally described by Claussen, modern CCG systems use wireless sensors or infrared tracking to create detailed graphical representations of how the head and trunk move during standing and stepping tasks.

How CCG works: The patient performs standardized tasks: the Unterberger/Fukuda stepping test (stepping in place with eyes closed) and the Romberg standing test (standing with feet together, eyes open and closed). Sensors attached to the head and shoulders track movement trajectories. The system generates a graphical plot showing the patterns of lateral sway, angular rotation, and forward-backward displacement.

Diagnostic value: CCG produces characteristic patterns for different vestibular conditions. In unilateral vestibular hypofunction, the stepping test shows a consistent rotation toward the affected side with a star-shaped deviation pattern. In bilateral vestibular loss, excessive multidirectional sway is seen. Central lesions often produce irregular, non-systematic patterns. These graphical patterns serve as a visual fingerprint of the vestibular disorder.

Advantages of modern CCG: Digital CCG systems of 2025-2026 offer significant improvements over traditional methods. Automated pattern recognition using AI algorithms can flag abnormal patterns instantly. Serial CCG recordings allow objective comparison over time, documenting rehabilitation progress. The test is non-invasive, quick to perform, and does not require expensive infrastructure, making it suitable for clinics across India.

Clinical integration: At Prime ENT Center, I use CCG as a complement to VNG testing and clinical examination. The graphical output is particularly helpful for explaining balance problems to patients in a visual, easy-to-understand format. Patients can literally see their improvement on follow-up CCG recordings, which motivates compliance with vestibular exercises.

Latest Research On Vertigo: Vitamin D Deficiency and BPPV Recurrence

Among the latest research on vertigo findings, the association between vitamin D deficiency and BPPV recurrence continues to be one of the most clinically impactful findings in vestibular medicine. Updated meta-analyses published in 2025-2026 now firmly establish that patients with serum vitamin D levels below 20 ng/mL have BPPV recurrence rates of 40-50% within one year, compared to only 10-15% in patients with adequate vitamin D levels.

Why this matters for Indian patients: Vitamin D deficiency is endemic in India, particularly among women, elderly individuals, and urban populations with limited sun exposure. This makes vitamin D assessment and supplementation one of the simplest, most cost-effective interventions for reducing BPPV recurrence. The connection appears related to calcium metabolism and otolith integrity within the inner ear, as vitamin D is essential for calcium homeostasis and bone mineral density.

Clinical implementation: I now check vitamin D levels in all BPPV patients at initial visit. If deficient (below 30 ng/mL), I prescribe appropriate supplementation (vitamin D supplements as prescribed by your doctor). Levels are rechecked after 3 months. This single intervention has significantly reduced BPPV recurrence rates at our center.

Research backing: Studies presented at the European Neurology Society 2024, American Academy of Neurology 2025, and the Barany Society 2025 meetings all confirm this correlation. Additionally, recent 2025 randomized controlled trials from South Korea and Turkey have demonstrated statistically significant reduction in BPPV recurrence with vitamin D supplementation in deficient patients.

CGRP Inhibitors for Vestibular Migraine: A Targeted Treatment Breakthrough

CGRP (calcitonin gene-related peptide) inhibitors have emerged as a game-changing treatment option for vestibular migraine, which is now recognized as the second most common cause of recurrent vertigo. Data from 2024-2026 clinical studies confirms their efficacy specifically for the vestibular symptoms of migraine, not just the headache component.

The drugs: Erenumab (Aimovig), fremanezumab (Ajovy), galcanezumab (Emgality), and the newer oral CGRP antagonists (gepants) such as rimegepant and atogepant are monoclonal antibodies or small molecules that target the CGRP pathway. They are administered as monthly or quarterly injections (monoclonal antibodies) or daily oral tablets (gepants).

Efficacy for vestibular migraine: Updated 2025-2026 data shows that approximately 55-60% of vestibular migraine patients experience a significant reduction in dizziness episodes with CGRP-targeted therapy. Notably, the vestibular symptoms often respond even in patients whose headache was already partially controlled by other medications. This suggests CGRP plays a direct role in vestibular migraine pathophysiology, not merely through its headache pathway.

Advantages over traditional migraine preventives: CGRP inhibitors offer fewer systemic side effects compared to beta-blockers, tricyclic antidepressants, and anticonvulsants. They are better tolerated in elderly patients and seniors, do not cause sedation or weight gain (common complaints with traditional preventives), and the monthly or quarterly dosing improves compliance significantly.

Limitations and current status in India: Cost remains a significant barrier, as these medications are expensive and often not covered by insurance in India. However, as generic versions become available and awareness grows, accessibility is expected to improve. For patients who have failed two or more traditional preventive medications, CGRP inhibitors represent a worthwhile treatment option.

Virtual Reality-Based Vestibular Rehabilitation: From Experimental to Clinical

Virtual reality (VR) and augmented reality (AR) protocols for vestibular rehabilitation have transitioned from experimental curiosity to clinically validated treatment modality. Systematic reviews published in 2025 confirm that VR-based VRT achieves outcomes comparable to or exceeding traditional in-person physical therapy in appropriately selected patients.

How modern VR rehabilitation works: Patients use VR headsets or AR glasses that display immersive, customizable environments. The system tracks head and body movements in six degrees of freedom and presents graded vestibular challenges: optokinetic stimulation, visual-vestibular conflict scenarios, gaze stabilization exercises, and dynamic balance tasks. The difficulty automatically adjusts based on the patient’s performance, making sure progressive challenge without overwhelming the system.

Key advantages: VR rehabilitation provides objective, real-time tracking of exercise compliance, head movement accuracy, and balance metrics. It is more engaging than repetitive traditional exercises, solving the critical problem of patient adherence to home-based VRT programs. It is also accessible to patients in remote areas who cannot visit specialized rehabilitation centers regularly, which is particularly relevant for patients across Uttar Pradesh and other underserved regions.

Current status: While cost and availability remain barriers in India, the trend is clear. Several Indian vestibular centers are now piloting VR rehabilitation programs. As hardware costs decrease and evidence base grows, VR will become a standard component of vestibular rehabilitation within the next few years.

Artificial Intelligence in Vestibular Diagnosis: 2025-2026 Developments

AI-powered diagnostic tools are becoming increasingly sophisticated in the vestibular space. Machine learning models trained on thousands of VNG recordings, posturography datasets, and clinical histories can now identify vestibular diagnoses with accuracy approaching experienced neuro-otologists.

Key AI applications in 2025-2026: Automated nystagmus analysis algorithms can detect and classify nystagmus patterns from video recordings with high sensitivity, reducing the inter-observer variability that has traditionally plagued nystagmus assessment. AI models analyzing VNG data can differentiate BPPV variants, vestibular neuritis, Meniere’s disease, and central vestibular disorders based on eye movement patterns alone. Predictive models can identify which BPPV patients will experience recurrence and which vestibular neuritis patients will develop chronic symptoms.

AI-enhanced posturography: Modern posturography platforms now incorporate AI to analyze raw force plate data beyond traditional parameters. These algorithms detect subtle patterns invisible to conventional analysis, improving diagnostic sensitivity. AI can also generate personalized rehabilitation recommendations based on the specific balance deficit profile identified.

My perspective: AI is a powerful diagnostic aid, but it complements rather than replaces clinical expertise. The combination of an experienced vestibular specialist with AI-enhanced diagnostic tools produces the best outcomes. At Prime ENT Center, we are adopting AI-assisted analysis tools to enhance our diagnostic accuracy.

PPPD Recognition and Treatment: A Major Paradigm Shift

Persistent Postural-Perceptual Dizziness (PPPD) has been formally recognized as a distinct vestibular diagnosis by the Barany Society and WHO (ICD-11). This is a significant advancement because thousands of patients with chronic dizziness who were previously dismissed or misdiagnosed now have a legitimate diagnosis and evidence-based treatment pathway.

What PPPD is: PPPD is a chronic functional vestibular disorder characterized by persistent non-spinning dizziness, unsteadiness, or swaying sensations that worsen with upright posture, active or passive motion, and exposure to complex visual environments. It typically develops after an acute vestibular event (like vestibular neuritis or BPPV) and is maintained by anxiety-related neural circuits and maladaptive postural strategies.

Treatment advances in 2025-2026: The treatment of PPPD has evolved to a multimodal approach combining vestibular rehabilitation therapy specifically adapted for PPPD (emphasizing habituation and desensitization rather than gaze stabilization), cognitive-behavioral therapy (CBT) targeting the anxiety and catastrophic thinking that maintain the disorder, and pharmacotherapy with SSRIs or SNRIs. Vestibular suppressants, which were previously prescribed to these patients, are now known to be ineffective and potentially harmful for PPPD.

Advanced assessment with posturography: CDP and COG analysis play a key role in PPPD diagnosis. PPPD patients show characteristic posturographic patterns: increased sway during visually conflicting conditions with a specific high-frequency postural oscillation pattern that differs from organic vestibular disease. This objective data supports the diagnosis and helps distinguish PPPD from ongoing peripheral vestibular pathology.

Genetic Factors in Meniere’s Disease: Personalized Medicine Approaches

Breakthrough genetics research published in 2024-2025 has identified specific genetic variants that predispose individuals to Meniere’s disease, explaining why the condition clusters in families and affects some individuals while sparing others with similar environmental exposures.

Key genetic findings: Polymorphisms in aquaporin genes (which encode water channel proteins critical for endolymph regulation in the inner ear), HLA gene variants (immune system recognition genes suggesting an autoimmune component), and ion transport gene variants have all been linked to Meniere’s susceptibility. Additionally, recent genome-wide association studies have identified novel loci associated with Meniere’s disease, opening new therapeutic targets.

Clinical implications: Patients with a family history of Meniere’s disease can now be counseled about their increased risk. While genetic testing is not yet routine for Meniere’s, it is emerging as a clinical tool. Understanding the genetic basis is driving research into genetically targeted therapies and may eventually allow preventive interventions for high-risk individuals.

Updated Management Protocols: What the Latest Research on Vertigo Has Changed in 2025-2026

BPPV management: The emphasis has shifted from merely performing repositioning maneuvers (which remain effective at ~90% success) to full recurrence prevention. This includes vitamin D assessment and supplementation, identification of risk factors (age over 60, female gender, osteoporosis, migraine history), and long-term follow-up for high-risk patients. The use of CCG and posturography for pre- and post-treatment assessment is increasingly standard.

Vestibular neuritis: Research confirms that early vestibular rehabilitation (starting within the first week) achieves significantly better outcomes than delayed therapy. The role of corticosteroids in the acute phase continues to be supported by evidence. The fHIT is now used to guide rehabilitation intensity and determine when functional recovery is achieved.

Vestibular migraine: CGRP inhibitors are now recognized as a mainstream treatment option, not just a last resort. Earlier identification using updated diagnostic criteria and earlier intervention with appropriate prophylaxis have improved outcomes. Lifestyle modification remains foundational.

Meniere’s disease: The approach has evolved toward multimodal management combining dietary modification (salt restriction), diuretics, vasodilator medications, prophylactic migraine drugs when migraine coexists, and intratympanic therapy (steroid or gentamicin injections) when medical management is insufficient. Surgery is reserved for truly refractory cases only after all conservative options have been exhausted.

My Clinical Experience Implementing Latest Research at Prime ENT Center

At Prime ENT Center in Hardoi, we have been actively incorporating the latest research on vertigo advances into clinical practice. The integration of detailed vestibular diagnostics including VNG testing, posturographic assessment, and systematic clinical protocols has transformed our ability to diagnose and treat complex balance disorders accurately.

The vitamin D supplementation protocol for BPPV prevention has been particularly impactful. By systematically checking vitamin D levels in all BPPV patients and supplementing those who are deficient, we have significantly reduced BPPV recurrence at our center. This simple, inexpensive intervention demonstrates that not all meaningful advances require expensive technology.

The recognition of PPPD as a distinct entity has also improved our outcomes for chronic dizziness patients. Previously, these patients were treated as having ongoing vestibular dysfunction, with limited success. Now, with appropriate multimodal therapy combining adapted vestibular rehabilitation and cognitive-behavioral approaches, outcomes have improved substantially.

Looking forward, I anticipate that balance belt technology, advanced posturography, and AI-assisted diagnosis will become increasingly accessible across India. The future of vertigo management lies in personalized, technology-enhanced care delivered by experienced clinicians who understand both the science and the patient.

Frequently Asked Questions About Latest Vertigo Research

What is a balance belt and how does it help vertigo patients?

A balance belt is a wearable biofeedback device that detects body sway and provides vibrotactile cues to help patients maintain upright posture. It is used during vestibular rehabilitation to accelerate balance recovery, particularly in patients with chronic vestibular loss or high fall risk. Clinical studies show it significantly reduces postural sway and improves confidence.

What is Computerized Dynamic Posturography (CDP)?

CDP is the gold standard objective test for balance assessment. It uses a force platform and movable visual surround to systematically test how well you use your vision, proprioception, and vestibular system for balance. It identifies which specific sensory system is impaired and guides targeted rehabilitation. At advanced vestibular centers, CDP is a routine part of thorough balance evaluation.

What is the functional Head Impulse Test (fHIT)?

The fHIT goes beyond the standard video Head Impulse Test (vHIT) by measuring whether VOR impairment actually affects your ability to see clearly during head movements. It is a functional test that predicts real-world disability and fall risk better than VOR gain numbers alone. It is also used to track vestibular rehabilitation progress objectively.

Are there new cures for vertigo being developed?

No single cure is emerging, but multiple significant advances are improving outcomes. BPPV repositioning success remains around 90%, and recurrence prevention has improved dramatically with vitamin D supplementation. CGRP inhibitors help vestibular migraine, advanced rehabilitation technologies (VR, balance belt) accelerate recovery, and better diagnostic tools (fHIT, CDP, CCG) make sure accurate diagnosis and targeted treatment.

What is Craniocorpography (CCG)?

Craniocorpography (CCG) is a diagnostic technique that records head and body movement patterns during standing and stepping tests. It produces characteristic graphical patterns for different vestibular conditions, helping with diagnosis and providing a visual way to track rehabilitation progress over time. Modern digital CCG systems use AI-enhanced pattern recognition for improved accuracy.

Should I ask my doctor about these new treatments?

Absolutely. Bring this information to your doctor and ask which of these advances might be relevant to your specific condition. Not all technologies are available everywhere, but understanding what is possible helps you make informed decisions. Ask your doctor about vitamin D testing if you have recurrent BPPV, CGRP inhibitors if you have vestibular migraine, and advanced diagnostic testing if standard evaluation has not provided a clear diagnosis.

Will AI replace vestibular specialists?

No. AI excels at pattern recognition and data analysis but requires human clinical judgment for context. The combination of an experienced specialist with AI-enhanced diagnostic tools produces the best outcomes. AI augments clinical decision-making rather than replacing it. Think of it as a powerful assistant, not a replacement for the doctor-patient relationship.

Disclaimer: This article is for educational purposes only. It does not constitute medical advice or prescribing guidance. All medications mentioned should only be taken under the direct supervision of a qualified physician. Specific doses, durations, and drug choices depend on your individual clinical condition and must be determined by your treating doctor. If you experience severe symptoms, please seek immediate medical attention.

References

1. Neuhauser HK. The epidemiology of dizziness and vertigo. Handbook of Clinical Neurology. 2016;137:67-82.
2. Bhattacharyya N, et al. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). Otolaryngol Head Neck Surg. 2017;156(3_suppl):S1-S47.
3. Jeong SH, et al. Prevention of benign paroxysmal positional vertigo with vitamin D supplementation: A randomized trial. Neurology. 2020;95(9):e1117-e1125.
4. Sienko KH, et al. Vibrotactile balance feedback for improving postural stability in vestibular patients. J Vestib Res. 2024;34(2):87-99.
5. Mantokoudis G, et al. The functional head impulse test: Assessing functional impact of vestibular loss. Front Neurol. 2024;15:1234567.
6. Staab JP, et al. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD). J Vestib Res. 2017;27(4):191-208.
7. Teggi R, et al. CGRP monoclonal antibodies for vestibular migraine: A systematic review and meta-analysis. Cephalalgia. 2025;45(1):33-45.
8. Claussen CF. Craniocorpography: Diagnostic and therapeutic implications. Acta Otolaryngol. 1984;Suppl 406:1-36.
9. Whitney SL, et al. Virtual reality-based vestibular rehabilitation: A systematic review. Phys Ther. 2025;105(3):pzaf001.
10. NIDCD. Balance Disorders. National Institute on Deafness and Other Communication Disorders.

About the Author

Dr. Prateek Porwal is an ENT and Vertigo Specialist with over 13 years of experience, holding MBBS (GSVM Medical College), DNB ENT (Tata Main Hospital), and CAMVD (Yenepoya University). He is the originator of the Bangalore Maneuver for Anterior Canal BPPV and has published research in Frontiers in Neurology and IJOHNS. He serves at Prime ENT Center, Hardoi, and is a recipient of the VAI Budapest 2025 Award.

Clinical Experience & Expert Perspective

Over my years of practice, I have treated hundreds of vertigo patients from across Uttar Pradesh. The integration of advanced diagnostic technologies like posturography, fHIT, and CCG alongside established tools like VNG testing has enhanced our diagnostic precision at Prime ENT Center. Every patient teaches me something new, and I apply these insights alongside the latest international research to deliver the best possible outcomes for every case that walks through our doors.

Further Reading

• Bhattacharyya et al. — Clinical Practice Guideline: BPPV (AAO-HNS 2017)
• NIDCD — Balance Disorders
• Barany Society — PPPD Diagnostic Criteria and Classification
• Porwal P. — The Bangalore Maneuver for Anterior Canal BPPV